Heart Failure 2019 - 6th World Congress on Acute Heart Failure

25 - 28 May 2019, Athens - Greece

Session Details

Poster Session 4: Chronic Heart Failure – Treatment
Tue 28 May 08:30 - 12:30 Other Poster Session Poster Area - Poster Area

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
08:30P2030Real life heart failure, a heterogeneous population benefiting from a specialized multidisciplinary programmeFrancisco ADRAGAO (Cascais, Portugal)
08:30P2031New approaches in personalized diagnose of patients with symptomatic obstructive hypertrophic cardiomyopathy optimize the type of treatment decision-making.Yulia FROLOVA (Moscow, Russian Federation)
08:30P2033Reassuring community heart failure care in the absence of specialist involvement; but some gaps indicate need for continued specialist team inputRebabonye PHARITHI (Dublin 16, Ireland)
08:30P2034Factors influencing guideline-led prescribing to heart failure patients in an Egyptian critical care settingSeif EL HADIDI (Cork, Ireland)
08:30P2035Meta-analysis on MitraClip implantation for functional mitral regurgitationMichel NOUTSIAS (Halle (Saale), Germany)
08:30P2036First-in-human VisONE heart failure study implant experience and study design: asymptomatic diaphragmatic stimulation for chronic heart failureAna JORBENADZE (Tbilisi, Georgia)
08:30P2037Heart failure patient's journey: clinical practices and attitudes regarding the diagnosis and management of heart failureMichael BOEHM (Homburg, Germany)
08:30P2038Service quality in a heart failure clinic: a comparison analysis to a general cardiology clinicLuiz Claudio DANZMANN (Porto Alegre, Brazil)
08:30P2040Consultant-led multidisciplinary community heart failure service improves the delivery of guideline directed medical therapy and reduces hospital admissions, re-admissions and length of stay.Tahir NAZIR (Manchester, United Kingdom of Great Britain & Northern Ireland)
08:30P2041Self-care management intervention in heart failureSofia GERWARD (Lund, Sweden)
08:30P2042OPTIMIZE Heart Failure Care Program in Mexico. Impact on early and mid term Heart Failure readmissions Jose Antonio MAGANA SERRANO (Mexico, Mexico)
08:30P2043Overcoming challenges in adopting guideline-based device therapy in patients with heart failure; a real-world experienceAnura MALAWEERA (Croydon, United Kingdom of Great Britain & Northern Ireland)
08:30P2044Clinical outcomes after renal replacement therapy in heart failure patients with cardiorenal syndrome and refractory congestion: a comparison between peritoneal dialysis and hemodialysisMarcus Vinicius SIMOES (Ribeirao Preto, Brazil)
08:30P2045Establishing the first pharmacist-led heart failure medication optimization clinic in the middle east gulf regionZiad SADIK (Abu Dhabi, United Arab Emirates)
08:30P2046Introduction of a multidisciplinary specialist heart failure team prevented 2 in 3 heart failure readmissions Carla PLYMEN (London, United Kingdom of Great Britain & Northern Ireland)
08:30P2047Current status of palliative care for heart failure; from the clinical experience of a general hospital in JapanYosuke NISHIHATA (Tokyo, Japan)
08:30P2048An evaluation of heart failure register reviews and virtual clinics 2016-2018Gayle CAMPBELL (London, United Kingdom of Great Britain & Northern Ireland)
08:30P2049Non-invasive Venous Waveform Analysis (NIVA) estimates static volume Monica POLCZ (, United States of America)
08:30P2050Vaccination uptake in HF patients; identifying a critical gap of careFaizan RATHORE (Skerries Co Dublin, Ireland)
08:30P2052Impact of a clinical pharmacy service on heart failure guideline-led prescribing at discharge in an Egyptian critical care unitMargaret BERMINGHAM (Cork, Ireland)
08:30P2053Multidisciplinary care for end-stage HF. How to improve care?Paula FLUVIA (Girona, Spain)